We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBZ icon
2276
CBIZ
CBZ
$2.96B
$55K ﹤0.01%
1,177
-2,127
-64% -$101K
CRDO icon
2277
Credo Technology Group
CRDO
$49.6B
$55K ﹤0.01%
4,096
-5,470
-57% -$72.6K
LZ icon
2278
LegalZoom.com
LZ
$993M
$55K ﹤0.01%
7,112
-21,730
-75% -$189K
OCSL icon
2279
Oaktree Specialty Lending
OCSL
$1.15B
$55K ﹤0.01%
2,677
+1,484
+124% +$29.9K
ONTO icon
2280
Onto Innovation
ONTO
$20.6B
$55K ﹤0.01%
807
-4,430
-85% -$318K
SITM icon
2281
SiTime
SITM
$20.7B
$55K ﹤0.01%
545
-6,216
-92% -$588K
THFF icon
2282
First Financial Corp
THFF
$975M
$55K ﹤0.01%
1,200
-1,159
-49% -$54.8K
TKNO icon
2283
Alpha Teknova
TKNO
$396M
$55K ﹤0.01%
9,696
-2,458
-20% -$10.9K
ALKS icon
2284
Alkermes
ALKS
$8.3B
$54K ﹤0.01%
2,048
-17,628
-90% -$422K
ATXS
2285
DELISTED
Astria Therapeutics
ATXS
$54K ﹤0.01%
3,626
+2,833
+357% +$29.2K
BCAB icon
2286
BioAtla
BCAB
$5.73M
$54K ﹤0.01%
132
+92
+230% +$38.2K
BEP icon
2287
Brookfield Renewable
BEP
$10.6B
$54K ﹤0.01%
2,147
-5,171
-71% -$148K
BYND icon
2288
Beyond Meat
BYND
$210M
$54K ﹤0.01%
4,450
-12,455
-74% -$173K
CNNE icon
2289
Cannae Holdings
CNNE
$675M
$54K ﹤0.01%
2,637
-1,953
-43% -$42.7K
FXL icon
2290
First Trust Technology AlphaDEX Fund
FXL
$2.89B
$54K ﹤0.01%
588
-7,812
-93% -$721K
IWB icon
2291
iShares Russell 1000 ETF
IWB
$50.5B
$54K ﹤0.01%
256
-36
-12% -$7.62K
NIC icon
2292
Nicolet Bankshares
NIC
$3.73B
$54K ﹤0.01%
667
-442
-40% -$34.4K
PBT
2293
Permian Basin Royalty Trust
PBT
$1.56B
$54K ﹤0.01%
2,161
+356
+20% +$7.36K
RC
2294
Ready Capital
RC
$294M
$54K ﹤0.01%
4,824
-17,538
-78% -$211K
VOOG icon
2295
Vanguard S&P 500 Growth ETF
VOOG
$27.4B
$54K ﹤0.01%
1,524
+1,482
+3,529% +$53.5K
TBRG
2296
DELISTED
TruBridge
TBRG
$54K ﹤0.01%
1,994
-2,704
-58% -$77.2K
SLCA
2297
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$54K ﹤0.01%
4,295
-16,892
-80% -$216K
CTMX icon
2298
CytomX Therapeutics
CTMX
$730M
$53K ﹤0.01%
33,103
+7,375
+29% +$10.9K
DAWN
2299
DELISTED
Day One Biopharmaceuticals
DAWN
$53K ﹤0.01%
2,436
+250
+11% +$5.13K
ELAN icon
2300
Elanco Animal Health
ELAN
$11.2B
$53K ﹤0.01%
4,394
-46,957
-91% -$585K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.